R.P. Scherer Corp said it isoffering 1.6 mln shares of 5-3/4 pct convertible exchangeablepreferred stock at 25 dlrs a share.    Each stock is convertible into the company's common stockat 23.60 dlrs a share, which represents a conversion premium of24.2 pct over the last sale price of 19 dlrs a share on March11.    Goldman, Sachs and Co is lead underwriter for the offering.    Scherer said one of its directors, Richard Manoogian, saidhe will buy 200,000 shares of the preferred stock at the same25 dlrs a share.    The company said proceeds will be used for generalcorporate purposes including funding an increasing commitmentto research and development on new drug formulations anddelivery systems. Reuter&#3;